Home > Healthcare > Pharmaceuticals > Clinical Nutrition > Vitamin D Therapy Market

Vitamin D Therapy Market Trends

  • Report ID: GMI9170
  • Published Date: Apr 2024
  • Report Format: PDF

Vitamin D Therapy Market Trends

  • Growing awareness of vitamin D deficiency is a key driver in the market. Public health campaigns and educational initiatives have emphasized the importance of maintaining adequate vitamin D levels for overall health, including bone health, immune function, and the prevention of chronic conditions.
     
  • Additionally, the global population is aging, particularly in developed countries, and older adults are more prone to vitamin D deficiency due to reduced skin synthesis and less time spent outdoors.
     
  • This demographic shift increases the demand for vitamin D therapy as older individuals seek to maintain bone density, muscle strength, and overall well-being. Additionally, older adults are more likely to have chronic conditions such as osteoporosis, which further drives the demand for vitamin D therapy.
     
  • Further, the availability of over-the-counter drugs (OTC) vitamin D makes it easy for consumers to access therapy without a prescription. This ease of access and affordability of OTC vitamin D supplements contribute significantly to market growth, as more people can take proactive steps to manage their vitamin D levels.
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global vitamin D therapy market size was valued at USD 2.9 billion in 2023 and is anticipated to showcase growth at 11.4% CAGR from 2024

The OTC drugs segment accounted 58.7% of the market share in 2023, due to its accessibility and convenience for consumers.

North America vitamin D therapy market accounted for 41.3% revenue share in 2023 and is predicted to reach USD 3 billion by 2032, owing to high prevalence of vitamin D deficiency and aging population.

Abbott Laboratories, Alkem Laboratories Ltd., Atrium Innovations, Biotics Research Corporation, Cadila Healthcare Ltd., GlaxoSmithKline plc, Merck & Co. Inc., Ortho Molecular Products, Pfizer, Inc., and Sanofi.

Vitamin D Therapy Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 10
  • Tables & Figures: 329
  • Countries covered: 22
  • Pages: 187
 Download Free Sample